Nordic Nanovector – Mature Data from the LYMRIT 37-01 – Part A trial, Published in Blood Advances
Oslo, Norway, 3[rd] September 2020 Nordic Nanovector ASA (OSE: NANO) announces the publication in Blood Advances, an official journal of the American Society of Hematology, of the mature data from the LYMRIT 37-01 – Part A trial (A. Kolstad et al. – ref. below). The data presented in this paper are aligned with the preliminary results presented by Dr Kolstad at the American Society of Hematology medical conference in December 2018: · Overall response rate (ORR) was 61% and complete response (CR) was 30% for all 74 patients · For patients with follicular lymphoma (FL), ORR